Table 1.

Expression Values (AU; mean ± SD) for Granzyme A, CD3, and IL-10 mRNA in Skin Samples

CD3Granzyme AIL-10
Mycosis fungoides 
Patch stage (n = 11) 387 ± 186* 132 ± 131 76 ± 73 
Plaque stage (n = 5) 407 ± 217* 196 ± 135 140 ± 95 
Tumor stage (n = 3) 620 ± 417 360 ± 200 283 ± 115 
Pleomorphic TCL (n = 5) 1,337 ± 599* 457 ± 181 574 ± 591 
Psoriasis (n = 7) 145 ± 164 49 ± 62 45 ± 16 
Atopic dermatitis (n = 5) 147 ± 61 44 ± 51 346 ± 302* 
Normal skin (n = 8) 64 ± 55 59 ± 60 44 ± 25 
CD3Granzyme AIL-10
Mycosis fungoides 
Patch stage (n = 11) 387 ± 186* 132 ± 131 76 ± 73 
Plaque stage (n = 5) 407 ± 217* 196 ± 135 140 ± 95 
Tumor stage (n = 3) 620 ± 417 360 ± 200 283 ± 115 
Pleomorphic TCL (n = 5) 1,337 ± 599* 457 ± 181 574 ± 591 
Psoriasis (n = 7) 145 ± 164 49 ± 62 45 ± 16 
Atopic dermatitis (n = 5) 147 ± 61 44 ± 51 346 ± 302* 
Normal skin (n = 8) 64 ± 55 59 ± 60 44 ± 25 

Abbreviation: TCL, T-cell lymphoma.

*

P < .01 (Mann-Whitney test) compared with normal skin. Granzyme A and IL-10 mRNA expression of the advanced stages of MF (plaque and tumor) but not of the early (patch) stage was significantly higher than in healthy and psoriatic skin (P < .01 Mann-Whitney test).

Close Modal

or Create an Account

Close Modal
Close Modal